ID2 and myeloid sarcoma: Excessive expression of Id2 triggered by fibrinogen deposition in demyelinated lesions of MS inhibits the translocation of class II bHLH TFs Olig1/2 into the nucleus, thus blocking the differentiation of OPCs into remyelinating oligodendrocyte (Petersen et al. 2017).